Business Lists and Databases Available for Marketing and Research - Direct Mailing Emailing Calling
NAICS Code 325414-04 - Serums & Vaccines (Manufacturing)
Marketing Level - NAICS 8-DigitBusiness Lists and Databases Available for Marketing and Research
Total Verified Companies:
22
Contact Emails:
211
Company Websites:
19
Phone Numbers:
17
Business Addresses:
22
Companies with Email:
16
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research
‐
Free Sample & Report, Custom Lists, and Expert Support — All Included
Business List Pricing Tiers
| Quantity of Records | Price Per Record | Estimated Total (Max in Tier) |
|---|---|---|
| 0 - 1,000 | $0.25 | Up to $250 |
| 1,001 - 2,500 | $0.20 | Up to $500 |
| 2,501 - 10,000 | $0.15 | Up to $1,500 |
| 10,001 - 25,000 | $0.12 | Up to $3,000 |
| 25,001 - 50,000 | $0.09 | Up to $4,500 |
| 50,000+ | Contact Us for a Custom Quote | |
What's Included in Every Standard Data Package
- Company Name
- Contact Name (where available)
- Job Title (where available)
- Full Business & Mailing Address
- Business Phone Number
- Industry Codes (Primary and Secondary SIC & NAICS Codes)
- Sales Volume
- Employee Count
- Website (where available)
- Years in Business
- Location Type (HQ, Branch, Subsidiary)
- Modeled Credit Rating
- Public / Private Status
- Latitude / Longitude
- ...and more (Inquire)
Boost Your Data with Verified Email Leads
Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!
Looking for more companies? See NAICS 325414 - Biological Product (except Diagnostic) Manufacturing - 524 companies, 44,663 emails.
NAICS Code 325414-04 Description (8-Digit)
Serums & Vaccines (Manufacturing) is a subdivision of the Biological Product (except Diagnostic) Manufacturing industry, which involves the production of biological products that are used for therapeutic and diagnostic purposes. This industry is responsible for the manufacturing of serums and vaccines that are used to prevent and treat various diseases. The production of serums and vaccines involves a complex process that requires a high level of expertise and precision.
Parent Code - Official US Census
Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 325414 page
Tools
Tools commonly used in the Serums & Vaccines (Manufacturing) industry for day-to-day tasks and operations.
- Bioreactors
- Centrifuges
- Chromatography systems
- Fermenters
- Incubators
- Lyophilizers
- Microscopes
- Pipettes
- Spectrophotometers
- Ultrafiltration systems
Industry Examples of Serums & Vaccines (Manufacturing)
Common products and services typical of NAICS Code 325414-04, illustrating the main business activities and contributions to the market.
- Influenza vaccine
- Measles vaccine
- Polio vaccine
- Rabies vaccine
- Tetanus vaccine
- Yellow fever vaccine
- Anti-venom serum
- Antitoxin serum
- Hepatitis B vaccine
- Meningococcal vaccine
History
A concise historical narrative of NAICS Code 325414-04 covering global milestones and recent developments within the United States.
- The manufacturing of serums and vaccines has a long and rich history dating back to the late 18th century when Edward Jenner developed the first vaccine for smallpox. Since then, the industry has made significant advancements, including the development of vaccines for various diseases such as polio, measles, and influenza. In the early 20th century, the industry saw a significant boost with the discovery of antibiotics, which led to the development of new vaccines and treatments. In recent years, the industry has been at the forefront of developing vaccines for emerging diseases such as Ebola, Zika, and COVID-19. In the United States, the industry has seen significant growth in the past decade, with the approval of new vaccines and the expansion of production facilities.